Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-14

Clinical Trial Update: Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pomalidomide with cyclophosphamide and dexamethasone for relapse/refractory multiple myeloma; safety profile in Mexican patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomalidomide/Cyclophosphamide/Dexamethasone

Snippet

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 2 | Status: UNKNOWN